Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/22221751.2020.1760145 http://scihub22266oqcxt.onion/10.1080/22221751.2020.1760145 32338155!7241459!32338155     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Emerg+Microbes+Infect 2020 ; 9 (1): 830-832 Nephropedia Template TP {{tp|p=32338155|t=2020. Rheumotologitsts view on the use of hydroxychloroquine to treat COVID-19 |pdf=|usr=}}{{32338155}} gab.com Text Rheumotologitsts view on the use of hydroxychloroquine to treat COVID-19 JO: Emerg Microbes Infect http://www.kidney.de/pget.php?&tw=1&pmid=32338155 #FOAvip The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti-malarial medicine chloroquine (CQ) and particularly its chemical analogue hydroxychloroquine (HCQ) have been recommended as promising candidate therapeutics that are now under either compassionate off-label use or clinical trials for the treatment of COVID-19 patients. However, there are public concerns and disputes about both the safety and efficacy of CQ and HCQ for this new application. Given the fact that for decades HCQ has been approved as an immunomodulatory drug for the long term treatment of chronic rheumatic diseases, as experienced rheumatologists, we would like to share our thoughts in this regard and trigger a brainstorm among clinical care providers for exchanging their diverse opinions on this urgent topic. Twit Text FOAVip Rheumotologitsts view on the use of hydroxychloroquine to treat COVID-19 ????Emerg Microbes Infect http://www.kidney.de/pget.php?&tw=1&pmid=32338155 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32338155 #FOAvip English Wikipedia <ref>{{Cite pmid|32338155}}</ref> Rheumotologitsts view on the use of hydroxychloroquine to treat COVID-19 #MMPMID32338155 Sun X; Ni Y; Zhang M Emerg Microbes Infect 2020[Dec]; 9 (1): 830-832 PMID32338155show ga The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti-malarial medicine chloroquine (CQ) and particularly its chemical analogue hydroxychloroquine (HCQ) have been recommended as promising candidate therapeutics that are now under either compassionate off-label use or clinical trials for the treatment of COVID-19 patients. However, there are public concerns and disputes about both the safety and efficacy of CQ and HCQ for this new application. Given the fact that for decades HCQ has been approved as an immunomodulatory drug for the long term treatment of chronic rheumatic diseases, as experienced rheumatologists, we would like to share our thoughts in this regard and trigger a brainstorm among clinical care providers for exchanging their diverse opinions on this urgent topic. |*Antimalarials/administration & dosage/adverse effects/therapeutic use[MESH] |*Antirheumatic Agents/administration & dosage/adverse effects/therapeutic use[MESH] |*Antiviral Agents/administration & dosage/adverse effects/therapeutic use[MESH] |*Hydroxychloroquine/administration & dosage/adverse effects/therapeutic use[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*drug therapy/epidemiology[MESH] |Humans[MESH] |Interdisciplinary Communication[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy/epidemiology[MESH] |Rheumatologists[MESH]Rheumotologitsts view on the use of hydroxychloroquine to treat COVID(epmc).pdf DeepDyve Pubget Overpricing